Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Nov 15;15:4687–4699. doi: 10.2147/DDDT.S329507

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Lu et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Intrathecal injection of RvD2 increased the PWT and micturition interval 24 h after intraperitoneal injection of CYP. (A) The effects of intrathecal injection of different drugs on the PWT (n=6). (B) Representative cystometrogram traces and (C–E) statistical analysis of the micturition interval, basal bladder pressure, and maximum bladder pressure before and after intrathecal injection of different drugs (n=5). Pre, before intrathecal injection of drugs; Post, after intrathecal injection of drugs. The arrows indicate the timing of intrathecal drug injection. One-way ANOVA and paired-samples t-test were used for statistical analysis, **P<0.01; ns, no significance.